Suppr超能文献

给予HSP72对缺血再灌注损伤的心脏保护作用。

Cardioprotective Effects of HSP72 Administration on Ischemia-Reperfusion Injury.

作者信息

Tanimoto Takashi, Parseghian Missag H, Nakahara Takehiro, Kawai Hideki, Narula Navneet, Kim Dongbin, Nishimura Robert, Weisbart Richard H, Chan Grace, Richieri Richard A, Haider Nezam, Chaudhry Farhan, Reynolds Glenn T, Billimek John, Blankenberg Francis G, Sengupta Partho P, Petrov Artiom D, Akasaka Takashi, Strauss H William, Narula Jagat

机构信息

Icahn School of Medicine at Mount Sinai, New York, New York; Wakayama Medical University, Wakayama, Japan.

Rubicon Biotechnology, Lake Forest, California.

出版信息

J Am Coll Cardiol. 2017 Sep 19;70(12):1479-1492. doi: 10.1016/j.jacc.2017.07.762.

Abstract

BACKGROUND

Although early reperfusion is the most desirable intervention after ischemic myocardial insult, it may add to damage through oxidative stress.

OBJECTIVES

This study investigated the cardioprotective effects of a single intravenous dose of heat shock protein-72 (HSP72) coupled to a single-chain variable fragment (Fv) of monoclonal antibody 3E10 (3E10Fv) in a rabbit ischemia-reperfusion model. The Fv facilitates rapid transport of HSP72 into cells, even with intact membranes.

METHODS

A left coronary artery occlusion (40 min) reperfusion (3 h) model was used in 31 rabbits. Of these, 12 rabbits received the fusion protein (Fv-HSP72) intravenously. The remaining 19 control rabbits received a molar equivalent of 3E10Fv alone (n = 6), HSP72 alone (n = 6), or phosphate-buffered saline (n = 7). Serial echocardiographic examinations were performed to assess left ventricular function before and after reperfusion. Micro-single-photon emission computed tomography imaging of Tc-labeled annexin-V was performed with micro-computed tomography scanning to characterize apoptotic damage in vivo, followed by gamma counting of the excised myocardial specimens to quantify cell death. Histopathological characterization of the myocardial tissue and sequential cardiac troponin I measurements were also undertaken.

RESULTS

Myocardial annexin-V uptake was 43% lower in the area at risk (p = 0.0003) in Fv-HSP72-treated rabbits compared with control animals receiving HSP72 or 3E10Fv alone. During reperfusion, troponin I release was 42% lower and the echocardiographic left ventricular ejection fraction 27% higher in the Fv-HSP72-treated group compared with control animals. Histopathological analyses confirmed penetration of 3E10Fv-containing molecules into cardiomyocytes in vivo, and treatment with Fv-HSP72 showed fewer apoptotic nuclei compared with control rabbits.

CONCLUSIONS

Single-dose administration of Fv-HSP72 fusion protein at the time of reperfusion reduced myocardial apoptosis by almost one-half and improved left ventricular functional recovery after myocardial ischemia-reperfusion injury in rabbits. It might have potential to serve as an adjunct to early reperfusion in the management of myocardial infarction.

摘要

背景

尽管早期再灌注是缺血性心肌损伤后最理想的干预措施,但它可能会通过氧化应激加重损伤。

目的

本研究在兔缺血再灌注模型中,研究了单次静脉注射与单克隆抗体3E10的单链可变片段(Fv)偶联的热休克蛋白-72(HSP72)的心脏保护作用。即使细胞膜完整,Fv也能促进HSP72快速转运到细胞内。

方法

对31只兔采用左冠状动脉闭塞(40分钟)再灌注(3小时)模型。其中,12只兔静脉注射融合蛋白(Fv-HSP72)。其余19只对照兔分别单独接受摩尔当量的3E10Fv(n = 6)、单独的HSP72(n = 6)或磷酸盐缓冲盐水(n = 7)。在再灌注前后进行系列超声心动图检查以评估左心室功能。用微型计算机断层扫描进行锝标记膜联蛋白-V的微型单光子发射计算机断层扫描成像,以在体内表征凋亡损伤,然后对切除的心肌标本进行γ计数以量化细胞死亡。还对心肌组织进行了组织病理学表征并进行了连续心肌肌钙蛋白I测量。

结果

与单独接受HSP72或3E10Fv的对照动物相比,Fv-HSP72治疗的兔梗死相关区域心肌膜联蛋白-V摄取降低43%(p = 0.0003)。在再灌注期间,与对照动物相比,Fv-HSP72治疗组的肌钙蛋白I释放降低42%,超声心动图左心室射血分数高27%。组织病理学分析证实含3E10Fv的分子在体内可穿透心肌细胞,与对照兔相比,Fv-HSP72治疗显示凋亡核较少。

结论

再灌注时单次给予Fv-HSP72融合蛋白可使兔心肌缺血再灌注损伤后的心肌凋亡减少近一半,并改善左心室功能恢复。它可能有潜力作为心肌梗死治疗中早期再灌注的辅助手段。

相似文献

1
Cardioprotective Effects of HSP72 Administration on Ischemia-Reperfusion Injury.
J Am Coll Cardiol. 2017 Sep 19;70(12):1479-1492. doi: 10.1016/j.jacc.2017.07.762.
5
Improved myocardial preservation with short hyperthermia prior to cold cardioplegic ischemia in immature rabbit hearts.
Eur J Cardiothorac Surg. 2000 Aug;18(2):233-40. doi: 10.1016/s1010-7940(00)00444-9.

引用本文的文献

2
Cathepsin B Nuclear Flux in a DNA-Guided "Antinuclear Missile" Cancer Therapy.
ACS Cent Sci. 2024 Jul 15;10(8):1562-1572. doi: 10.1021/acscentsci.4c00559. eCollection 2024 Aug 28.
7
Cellular protection from HO toxicity by Fv-Hsp70: protection via catalase and gamma-glutamyl-cysteine synthase.
Cell Stress Chaperones. 2023 Jul;28(4):429-439. doi: 10.1007/s12192-023-01349-6. Epub 2023 May 12.
10
Mechanism of Phosgene-Induced Acute Lung Injury and Treatment Strategy.
Int J Mol Sci. 2021 Oct 10;22(20):10933. doi: 10.3390/ijms222010933.

本文引用的文献

2
Cyclosporine A in Reperfused Myocardial Infarction: The Multicenter, Controlled, Open-Label CYCLE Trial.
J Am Coll Cardiol. 2016 Feb 2;67(4):365-374. doi: 10.1016/j.jacc.2015.10.081.
3
CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis.
Nat Med. 2016 Feb;22(2):175-82. doi: 10.1038/nm.4017. Epub 2016 Jan 4.
4
Cyclosporine before PCI in Patients with Acute Myocardial Infarction.
N Engl J Med. 2015 Sep 10;373(11):1021-31. doi: 10.1056/NEJMoa1505489. Epub 2015 Aug 30.
5
DNA-dependent targeting of cell nuclei by a lupus autoantibody.
Sci Rep. 2015 Jul 9;5:12022. doi: 10.1038/srep12022.
6
Evolving therapies for myocardial ischemia/reperfusion injury.
J Am Coll Cardiol. 2015 Apr 14;65(14):1454-71. doi: 10.1016/j.jacc.2015.02.032.
7
Developing a STEMI system of care for low- and middle-income countries: the STEMI-India model.
Glob Heart. 2014 Dec;9(4):419-23. doi: 10.1016/j.gheart.2014.04.005.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验